Molina Healthcare, Inc. (MOH) — Fair Value Analysis

Base-case fair value (P50): $261.70 · Current price: $195.37 · Verdict: Undervalued

The Verdict on MOH

Our Monte Carlo simulations indicate that MOLINA HEALTHCARE INC (MOH) is Deeply Undervalued at its current price of $195.37. The P50 (median) fair value derived from thousands of forward-looking scenarios stands at $261.70, suggesting a significant +34.0% upside potential from the current market price. This assessment is based on a comprehensive probabilistic analysis, mapping potential operational and financial trajectories for MOH. The gap between $195.37 and $261.70 highlights a compelling entry point for investors seeking value in the current market.

How MOH stacks up against peers

MOH's operational and financial health is rated as "average" within its sector. Despite this average quality tier, the substantial upside to our $261.70 fair value of $261.70 compared to the $195.37 suggests that the market may be overlooking MOLINA HEALTHCARE INC's intrinsic value. An average quality tier company with a Deeply Undervalued rating often represents a scenario where robust valuation models identify a discrepancy between market perception and underlying fundamental potential, as reflected in the +34.0% differential.

What this means for investors

For investors, the +34.0% projected upside from $195.37 to the $261.70 fair value presents a clear opportunity. While the quality tier is average, the deep undervaluation shown by our Monte Carlo analysis points to a mispricing that could correct over time. Understanding the probabilistic range of outcomes is crucial, and our FairCurve analysis provides context beyond just the median. To see the full bear/bull distribution and track MOH's fair value as new fundamentals are released, sign up for a free FairCurve account.